Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Prendergast

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|March 22, 2002
Mode of action of farnesyltransferase inhibitorsG C Prendergast
Nature Reviews. Cancer|March 22, 2002
Actin' up: RhoB in cancer and apoptosisG C Prendergast
Nature Biotechnology|October 3, 2001
Knockout drug screensG C Prendergast
Oncogene|June 23, 1999
Myc and Myb: are the veils beginning to lift?G C Prendergast
Histology and Histopathology|February 24, 2001
Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiologyG C Prendergast
Current Opinion in Cell Biology|March 14, 2000
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospectsG C Prendergast
Oncogene|June 23, 1999
Mechanisms of apoptosis by c-MycG C Prendergast
Oncogene|March 5, 2008
Immune escape as a fundamental trait of cancer: focus on IDOG C Prendergast
Histology and Histopathology|December 6, 2005
RhoB in cancer suppressionM Huang, G C Prendergast
Expert Opinion on Investigational Drugs|January 5, 2002
Farnesyltransferase inhibitors: mechanism and applicationsG C Prendergast, N Rane
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|March 22, 2002
Mode of action of farnesyltransferase inhibitorsG C Prendergast
Nature Reviews. Cancer|March 22, 2002
Actin' up: RhoB in cancer and apoptosisG C Prendergast
Nature Biotechnology|October 3, 2001
Knockout drug screensG C Prendergast
Oncogene|June 23, 1999
Myc and Myb: are the veils beginning to lift?G C Prendergast
Histology and Histopathology|February 24, 2001
Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiologyG C Prendergast
Current Opinion in Cell Biology|March 14, 2000
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospectsG C Prendergast
Oncogene|June 23, 1999
Mechanisms of apoptosis by c-MycG C Prendergast
Oncogene|March 5, 2008
Immune escape as a fundamental trait of cancer: focus on IDOG C Prendergast
Histology and Histopathology|December 6, 2005
RhoB in cancer suppressionM Huang, G C Prendergast
Expert Opinion on Investigational Drugs|January 5, 2002
Farnesyltransferase inhibitors: mechanism and applicationsG C Prendergast, N Rane
Pageof 7